BioVolume is the world’s first 3D imaging solution that has been developed in partnership with a leading pharmaceutical company and wider industry for visualising and measuring subcutaneous tumour growth in preclinical oncology research.

It was conceived to enable faster, smarter and more confident decisions to be made in the identification and development of new cancer therapeutics.

BioVolume is a part of the Fuel3D Group of companies fuel3d.com

Biotechnology

Life Sciences

BioVolume

BioVolume's headquarters in Oxford, United Kingdom

Description

People (1)

Jobs (0)

Other offices